24 results for “environment”
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s […]
We take a look at the dark side of the disposable CBD vapes which have flooded the market in recent years.
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
A comprehensive guide on how to read and interpret cannabis research.
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in […]
Dr Sue Clenton, Medical Director at Releaf explores the role that clinics can play in recruiting and training the next generation of medical cannabis professionals.
A cancer patient, using medical cannabis to manage the side effects of chemotherapy, developed a life-threatening fungal infection after using a contaminated product.
Two cannabis-derived compounds have shown remarkable effectiveness against fungal pathogens in laboratory tests, according to new research. In a study published in The Journal of Neglected Tropical Diseases (PLOS NTDs), researchers […]
A new pilot project has found that medical cannabis may help with recovery from substance use challenges.
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner.
The UK Government is being sued by a CBD business for £3.4m, in the latest major challenge to its mishandling of legal hemp. Ocean Development (Dorset) Ltd. and connected retail […]
The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by […]
A formulation combining medical cannabis with Ayurvedic remedies may be an effective alternative treatment.
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of the Citizens’ Assembly.
The majority of doctors can now prescribe for reimbursement without prior approval of the health insurance companies.
While CBD is generally considered to be safe, new animal studies have shown alterations in brains and behaviour in offspring exposed to the cannabinoid during pregnancy. The International Cannabis Policy […]
The first domestically grown medical cannabis is now available to patients in the UK.
Bundesrat votes in favour of CanG, with law set to come in on 1 April.
